SCHEMBL7651199

SCHEMBL7651199

OCc1cn(-c2nc3ccccc3cc2I)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.48
NOTUM Q6P988 3/20 0.35
GRM5 P41594 1/20 0.34
GRM1 Q13255 1/20 0.34
ALDH1A1 P00352 4/20 0.33
TDP1 Q9NUW8 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GLA P06280 1/20 0.33
ACHE P22303 1/20 0.33
GPBAR1 Q8TDU6 2/20 0.33
CYSLTR1 Q9Y271 2/20 0.33
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
ADORA2A P29274 1/20 0.32
PKM P14618 1/20 0.31
AGER Q15109 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4427850 0.75 CYP11B1 (0.54) PDE10ANOTUMALDH1A1PDE3BPDE3A
SCHEMBL4428136 0.74 PDE10A (0.61) PDE10AALDH1A1TDP1MAPTKDM4E
SCHEMBL25061854 0.72 SORD (0.47) PDE10AALDH1A1TDP1L3MBTL1MAPT
SCHEMBL21434928 0.72 GRM5 (0.41) PDE10ANOTUMGRM5GRM1L3MBTL1
SCHEMBL4433578 0.70 NOTUM (0.56) PDE10ANOTUML3MBTL1HPGDKDM4E
SCHEMBL4427538 0.69 PDE10A (0.41) PDE10ANOTUML3MBTL1MAPTPDE3B
SCHEMBL4422256 0.69 NCOA3 (0.56) PDE10ANOTUMALDH1A1L3MBTL1MAPT
SCHEMBL1506695 0.68 ALDH1A1 (0.46) ALDH1A1TDP1MAPTHPGDKDM4E
SCHEMBL4433834 0.68 CPB2 (0.50) PDE10ANOTUMALDH1A1L3MBTL1MAPT
SCHEMBL4425401 0.67 PDE3B (0.40) PDE10ANOTUMGRM5GRM1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020151715-A1 Imidazole derivatives EVOTEC INTERNATIONAL GMBH (DE) 2002-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151715-A1 Imidazole derivatives GRIN2B, GRIN1, GRIN2A PDE10A 1675/4885NOTUM 4107/4885GRM5 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.